Milestone Scientific Inc. (NYSE:MLSS – Get Free Report)’s share price traded up 2% on Friday . The stock traded as high as $0.4030 and last traded at $0.3990. 125,254 shares were traded during trading, a decline of 88% from the average daily volume of 1,027,132 shares. The stock had previously closed at $0.3911.
Milestone Scientific Price Performance
The stock has a market cap of $35.29 million, a P/E ratio of -5.70 and a beta of 1.05. The company’s 50 day simple moving average is $0.37 and its 200 day simple moving average is $0.32.
Institutional Trading of Milestone Scientific
A hedge fund recently raised its stake in Milestone Scientific stock. Raymond James Financial Inc. increased its holdings in shares of Milestone Scientific Inc. (NYSE:MLSS – Free Report) by 416.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 62,000 shares of the company’s stock after buying an additional 50,000 shares during the quarter. Raymond James Financial Inc. owned 0.08% of Milestone Scientific worth $39,000 as of its most recent SEC filing. 5.79% of the stock is currently owned by hedge funds and other institutional investors.
About Milestone Scientific
Milestone Scientific, Inc, listed on the New York Stock Exchange under the symbol MLSS, is a medical device company specializing in the development and commercialization of computer-controlled injection technologies for local anesthesia and pain management. The company’s proprietary systems are designed to enhance patient comfort, improve clinical outcomes and streamline the administration of anesthetics in dental and medical procedures. Through its precision delivery platforms, Milestone Scientific aims to set a new standard for minimally invasive injections.
At the core of Milestone Scientific’s product portfolio is the Single Tooth Anesthesia (STA) System, which uses Comunication Controlled Local Anesthetic Delivery (CCLAD) technology to provide targeted, atraumatic anesthesia for individual dental roots.
See Also
- Five stocks we like better than Milestone Scientific
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
